Literature DB >> 21382471

In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.

Manojkumar Valiyaveettil1, Yonas Alamneh, Lionel Biggemann, Iswarduth Soojhawon, Heba A Farag, Prashasthi Agrawal, Bhupendra P Doctor, Madhusoodana P Nambiar.   

Abstract

Paraoxonase 1 (PON1) has been described as a potential catalytic bioscavenger due to its ability to hydrolyze organophosphate (OP) insecticides and nerve agents. In vitro catalytic efficiency of purified human and rabbit serum PON1 against different OP substrates was compared to human recombinant PON1, expressed in Trichoplusia ni larvae. Highly purified human and rabbit serum PON1s were prepared by multiple chromatography methods. Purified enzymes showed higher catalytic activity with the substrate p-nitrophenyl acetate compared to diethyl paraoxon. The hydrolyzing potential of PON1s against multiple OPs was evaluated by using an in vitro acetylcholinesterase back-titration assay. Significant differences in the catalytic efficiency of all the three PON1s with regard to various OP substrates were observed. Purified PON1s showed higher catalytic activity towards diisopropylfluorophosphate followed by diethylparaoxon compared to dimethyl paraoxon. Heat inactivation or incubation of PON1 with specific inhibitor resulted in complete loss of the enzyme catalytic activity indicating that OP hydrolysis was intrinsic to PON1. In conclusion, purified PON1s from multiple sources show significant differences in the catalytic activity against several OP substrates. These results underscore the importance of systematic analysis of candidate PON1 molecules for developing as an effective catalytic bioscavenger against toxic OPs and chemical warfare nerve agents. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382471     DOI: 10.1016/j.tiv.2011.02.012

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

1.  In vitro detoxification of cyclosarin in human blood pre-incubated ex vivo with recombinant serum paraoxonases.

Authors:  Yacov Ashani; Moshe Goldsmith; Haim Leader; Israel Silman; Joel L Sussman; Dan S Tawfik
Journal:  Toxicol Lett       Date:  2011-07-23       Impact factor: 4.372

2.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

Review 3.  Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1.

Authors:  Thomas M Polasek; Matthew P Doogue; John O Miners
Journal:  Ther Adv Drug Saf       Date:  2011-12

4.  The effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patients.

Authors:  Anis Kouchak; Mahmoud Djalali; Mohamadreza Eshraghian; Ahmad Saedisomeolia; Abolghassem Djazayery; Hossein Hajianfar
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

Review 5.  Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  ScientificWorldJournal       Date:  2014-10-20

6.  Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering.

Authors:  Miha Purg; Mikael Elias; Shina Caroline Lynn Kamerlin
Journal:  J Am Chem Soc       Date:  2017-11-21       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.